Search | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Filgrastim

    ... the skin (subcutaneous) or in the vein (intravenous). Filgrastim is approved by the U.S. Food and Drug Administration (FDA) for ...

    Drug last updated 03/24/2016 - 12:32pm.

  2. MDS Follows Two Misdiagnoses

    ... infusion and epoetin alfa (Procrit®) and filgrastim (Neupogen®) shots are keeping me close to stable. I did ...

    Patient Chronicle last updated 12/27/2016 - 7:23am.

  3. Filgrastim, Cladribine, Cytarabine and Mitoxantrone With or Without Sorafenib Tosylate in Treating Patients With Newly-Diagnosed, High-Risk Acute Myeloid Leukemia or Myelodysplastic Syndrome

    ... I/II trial studies the side effects and best dose of filgrastim ( granulocyte colony-stimulating factor [G-CSF]), ... (high-risk). Drugs used in chemotherapy , such as filgrastim, cladribine, cytarabine, and mitoxantrone hydrochloride work in ...

    Clinical Trial last updated 04/29/2016 - 1:03pm.

  4. Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

    ... of mitoxantrone hydrochloride when given together with filgrastim , cladribine, and cytarabine and to see how well they work in ... to treatment. Drugs used in chemotherapy , such as filgrastim, cladribine, cytarabine, and mitoxantrone hydrochloride, work in ...

    Clinical Trial last updated 04/28/2016 - 1:17pm.

  5. Optimizing Cord Blood and Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502) (CHAMP)

    ... Cyclophosphamide Filgrastim Fludarabine Mycophenolate ...

    Clinical Trial last updated 05/22/2017 - 11:00am.

  6. Preventing Stem Cell Transplant Complications With a Blood Separator Machine

    ... After the first collection, participants will have filgrastim injections to help their stem cells enter their blood. ... provided breast milk is discarded during the days filgrastim (G-CSF) is given 5.4.2 Unfit to receive G-CSF and undergo ...

    Clinical Trial last updated 05/23/2016 - 10:57am.

  7. Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

    ... disease (cGVHD) occurs less commonly with BM compared to filgrastim (G-CSF) mobilized peripheral blood stem cell (PBSC) transplants, ... Pregnant or lactating Unfit to receive filgrastim (G-CSF) or undergo apheresis (history of stroke, MI, unstable ...

    Clinical Trial last updated 04/28/2016 - 2:40pm.

  8. Horse ATG in Patients With AA or Low/Int-1 Risk MDS

    ... On Day 5 (or starting on Day 5) you will receive filgrastim or pegfilgrastim by an injection under your skin. Your doctor ... you will receive it one time on Day 5. If you receive filgrastim, you will receive it starting on Day 5. You will continue to receive ...

    Clinical Trial last updated 04/27/2016 - 10:30am.

  9. Clinical Trials Report for April 2016

    ... methylprednisolone, cyclosporine , and G-CSF ( filgrastim or pegfilgrastim), can help to control AA and/or low-int-1 risk ...

    Page last updated 08/10/2016 - 11:00am.

  10. Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi Anemia

    ... cell transplantation on day 0. Patients also receive filgrastim (G-CSF) IV beginning on day 1 and continuing until blood counts ... for ATG on day -6 to -2. Other Name: MP Drug: filgrastim Initiate G-CSF 5 mcg/kg per day intravenously (IV) continue ...

    Clinical Trial last updated 04/28/2016 - 8:53am.